In Episode 2 of Unlocking Antiarrhythmics From ABCs to Action, #HRStv host Deepthy Varghese, DNP, ACNP, FNP is joined by Jose L. Merino, MD, PhD to explore what it means to truly personalize antiarrhythmic drug (AAD) therapy across diverse patient populations. Together, they discuss real-world strategies for tailoring treatment based on age, comorbidities, arrhythmia type, and individual risk factors — highlighting how precision medicine is reshaping rhythm management. From dosing considerations to emerging research and clinical challenges, viewers will gain actionable insight to help optimize AAD use in varied care settings and deliver more confident, patient-centered treatment.
Stay tuned for Episode 3: Wearables and AADs: Next-Gen Rhythm Monitoring at Home
Additional Resources
https://academic.oup.com/europace/article/27/8/euaf076/8100306?login=true
https://www.jacc.org/doi/10.1016/j.jacep.2024.11.020
Listen on:
Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
Resource Type
- HRStv Podcast
Related Resources
HRStv Podcast
Episode 136: ACC 2026 – The CHAMPION AF Trial
March 29, 2026
HRStv Podcast
Episode 135: ICE Image of the Month – PFA and VT Ablation (Part II)
March 20, 2026
HRStv Podcast
Episode 134: Obesity, GLP 1s, and the Missing Link in AFib Care
March 6, 2026